Tuesday, November 24, 2009, 6:00am EST - Canadian Markets open in 3 hours and 30 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Smith & Nephew plc (SNN)

 On Nov 23: 48.03 USD   0.00 (0.00%)  
MORE ON SNN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
SMITH&NEPHEW PLC NEW (NYSE:SNN) Delayed quote dataEdit
Last Trade: 48.03 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 48.03
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 44.67
Day's Range: N/A - N/A
52wk Range: 30.01 - 48.95
Volume: 0
Avg Vol (3m): 77,369.2
Market Cap: 8.48B
P/E (ttm): 18.47
EPS (ttm): 2.60
Div & Yield: 0.68 (1.41%)
Smith & Nephew plc (SNN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add SNN to Portfolio   Download Data

HEADLINES
• [$$] A Time to Fight, a Time to Heal
at Barrons.com (Sat, Nov 21)
• Smith & Nephew wins Department of Defense contract
at bizjournals.com (Fri, Nov 20)
• Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries "Fracture putty" system to improve standard of care
PRNewswire (Fri, Nov 20)
• Smith & Nephew Supports New CPT Code for Multi-Layer Compression Bandaging Systems
PRNewswire (Thu, Nov 19)
• Smith & Nephew Endoscopy Announces Availability of TRUCLEAR(TM) Hysteroscopic Morcellator at the AAGL Annual Meeting Innovative System Allows for Eff
PRNewswire (Tue, Nov 17)
• Zimmer to Sell Notes
Zacks.com (Fri, Nov 13)
• Stryker Strikes Acquisition Deals
Zacks.com (Thu, Nov 12)
• Wright Receives FDA Approval
Zacks.com (Wed, Nov 11)
• Smith & Nephew to buy Nucryst assets for $21 mln
at MarketWatch (Wed, Nov 11)
• Centers for Medicare & Medicaid Services Retain Single NPWT Code Significant decision will benefit patients, providers
PRNewswire (Mon, Nov 9)
• Q3 2009 Smith & Nephew Earnings Release - 02:00 am ET
CCBN (Fri, Nov 6)
• Smith & Nephew Earnings Call scheduled for 3:30 am ET today
CCBN (Fri, Nov 6)
• Smith & Nephew net profit jumps 73%, revenue slips
at MarketWatch (Fri, Nov 6)
More Headlines for SNN...
ANALYST
EPS Est (next year) (Dec-09) : 3.01
EPS Est (in 2 years) (Dec-10) : 3.27
Avg Rec (current)*: 3.0
PEG Ratio: 1.44
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Smith & Nephew plc, together with its subsidiaries, engages in the development, manufacture, marketing, and sale of medical devices worldwide. The company operates through three segments: Orthopaedics, Endoscopy, and Advanced Wound Management.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices